These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18665064)

  • 1. Implications of comorbidity on costs for patients with Alzheimer disease.
    Kuo TC; Zhao Y; Weir S; Kramer MS; Ash AS
    Med Care; 2008 Aug; 46(8):839-46. PubMed ID: 18665064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy.
    Fillit H; Hill JW; Futterman R
    Fam Med; 2002; 34(7):528-35. PubMed ID: 12144008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health service utilization among Alzheimer's disease patients: evidence from managed care.
    Frytak JR; Henk HJ; Zhao Y; Bowman L; Flynn JA; Nelson M
    Alzheimers Dement; 2008 Sep; 4(5):361-7. PubMed ID: 18790463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
    Menzin J; Boulanger L; Marton J; Guadagno L; Dastani H; Dirani R; Phillips A; Shah H
    Respir Med; 2008 Sep; 102(9):1248-56. PubMed ID: 18620852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare costs and utilization for Medicare beneficiaries with Alzheimer's.
    Zhao Y; Kuo TC; Weir S; Kramer MS; Ash AS
    BMC Health Serv Res; 2008 May; 8():108. PubMed ID: 18498638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease.
    Zhu CW; Scarmeas N; Torgan R; Albert M; Brandt J; Blacker D; Sano M; Stern Y
    Neurology; 2006 Sep; 67(6):998-1005. PubMed ID: 16914696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of Alzheimer's disease and association with negative health outcomes.
    Malone DC; McLaughlin TP; Wahl PM; Leibman C; Arrighi HM; Cziraky MJ; Mucha LM
    Am J Manag Care; 2009 Aug; 15(8):481-8. PubMed ID: 19670951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain.
    Lopez-Bastida J; Serrano-Aguilar P; Perestelo-Perez L; Oliva-Moreno J
    Neurology; 2006 Dec; 67(12):2186-91. PubMed ID: 17190942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost of Alzheimer's disease in managed care: a cross-sectional study.
    Leon J; Neumann PJ
    Am J Manag Care; 1999 Jul; 5(7):867-77. PubMed ID: 10557408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying diagnostic cost groups to examine the disease burden of VA facilities: comparing the six "Evaluating VA Costs" study sites with other VA sites and Medicare.
    Rosen AK; Loveland S; Anderson JJ
    Med Care; 2003 Jun; 41(6 Suppl):II91-102. PubMed ID: 12773831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care cost associated with prostate cancer, androgen deprivation therapy and bone complications.
    Krupski TL; Foley KA; Baser O; Long S; Macarios D; Litwin MS
    J Urol; 2007 Oct; 178(4 Pt 1):1423-8. PubMed ID: 17706711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic implications of comorbid conditions among Medicaid beneficiaries with COPD.
    Lin PJ; Shaya FT; Scharf SM
    Respir Med; 2010 May; 104(5):697-704. PubMed ID: 19954941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic burden and co-morbidities of atrial fibrillation in a privately insured population.
    Wu EQ; Birnbaum HG; Mareva M; Tuttle E; Castor AR; Jackman W; Ruskin J
    Curr Med Res Opin; 2005 Oct; 21(10):1693-9. PubMed ID: 16238910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain.
    Boulanger L; Zhao Y; Foster TS; Fraser K; Bledsoe SL; Russell MW
    Curr Med Res Opin; 2009 Jul; 25(7):1763-73. PubMed ID: 19505204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An examination of Alzheimer's disease case definitions using Medicare claims and survey data.
    Lin PJ; Kaufer DI; Maciejewski ML; Ganguly R; Paul JE; Biddle AK
    Alzheimers Dement; 2010 Jul; 6(4):334-41. PubMed ID: 20434960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacoeconomics of Alzheimer's disease.
    Fillit HM
    Am J Manag Care; 2000 Dec; 6(22 Suppl):S1139-44; discussion S1145-8. PubMed ID: 11142178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of illness among commercially insured patients with Alzheimer's disease.
    Joyce AT; Zhao Y; Bowman L; Flynn JA; Carter CT; Ollendorf DA
    Alzheimers Dement; 2007 Jul; 3(3):204-10. PubMed ID: 19595939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-diagnosis excess acute care costs in Alzheimer's patients among a US Medicaid population.
    Geldmacher DS; Kirson NY; Birnbaum HG; Eapen S; Kantor E; Cummings AK; Joish VN
    Appl Health Econ Health Policy; 2013 Aug; 11(4):407-13. PubMed ID: 23700254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
    Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.